NYC Health and Hospitals (Elmhurst) Cardiovascular Disease

Topics

• Atrial Fibrillation Management and Outcomes 227
• Peripheral Artery Disease Management 20
• Cardiac Valve Diseases and Treatments 19
• Acute Myocardial Infarction Research 15
• Cardiac, Anesthesia and Surgical Outcomes 14
• Venous Thromboembolism Diagnosis and Management 14
• Cardiac pacing and defibrillation studies 12
• Cerebrovascular and Carotid Artery Diseases 11
• Heart Failure Treatment and Management 10
• Antiplatelet Therapy and Cardiovascular Diseases 9
• Coronary Interventions and Diagnostics 9
• COVID-19 Clinical Research Studies 9

Most cited

1. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.

   Circulation · 2022 · 353 citations · Jonathan Halperin

2. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.

   JAMA internal medicine · 2021 · 372 citations · Jonathan Halperin

3. The Effects of Obstructive Sleep Apnea on the Cardiovascular System: A Comprehensive Review.

   Journal of clinical medicine · 2024 · 57 citations · Brianna Yee

4. Left Ventricular Thrombus Following Acute Myocardial Infarction: JACC State-of-the-Art Review.

   Journal of the American College of Cardiology · 2022 · 151 citations · Jonathan Halperin

5. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.

   JAMA · 2022 · 85 citations · Jonathan Halperin

6. Pathophysiology, Echocardiographic Diagnosis, and Treatment of Atrial Functional Mitral Regurgitation: JACC State-of-the-Art Review.

   Journal of the American College of Cardiology · 2022 · 100 citations ·